Study overview: Researchers from Alliance Medical (Europe) analyzed oncologic PET-CT scans in patients receiving GLP-1 therapy and observed abnormal fluorodeoxyglucose (FDG) uptake patterns that could easily be mistaken for pathological hot spots. In some cases, what appears to be malignant metabolic activity may, in fact, represent drug-induced metabolic redistributionlikely linked to delayed gastric emptying and altered glucose metabolism caused by GLP-1 agonism
Muscle Is Extremely Hard to Regain Especially as You Age Unlike fat, muscle is not easily regained, particularly for : - Adults over 35 - Individuals with hormonal changes - Those who have dieted aggressively multiple times After muscle loss : - Rebuilding requires resistance training - Adequate protein intake - Time, consistency, and recovery Many people who lose muscle on GLP-1 medications never fully regain it, leaving them metabolically disadvantaged long term
da Silva Bandeira BE, Dos Santos Jnior A, Dalgalarrondo P, de Azevedo RCS, Celeri EHVR
The change in glycine, another GSH precursor, was not significant ( P = 0.08)
(for example, by mouth, injection, etc.) In addition to the medication, what else should I be doing
Last reviewed 2026-07-03